Founded in 1998, Aldevron creates, develops, manufactures and markets a full line of non-Good Manufacturing Process contract plasmid Deoxyribonucleic acid products and provides numerous related services. The company can also manufacture plasmid DNA under state-of-the-art GMP conditions for clinical applications. The company s core technology is a proprietary method to produce and purify plasmid DNA developed by the company s founders, John Ballantyne and Michael Chambers. Its products include research-and clinical-grade plasmid DNA, GMP-source plasmid DNA, gene therapy plasmids, genetic immunizations and antibodies, HBsAg products, UMVC gene therapy plasmids, gWIZ Reporter plasmids and a complete range of OEM and contract protein services. Aldevron maintains its corporate offices, research and production facilities in Fargo, N.D. and has additional operations in Friedberg, Germany.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.